
Trean Insurance Group TIG
Geschäftsbericht 2022
hinzugefügt 16.03.2023
Trean Insurance Group P/S 2011-2026 | TIG
P/S Jährlich Trean Insurance Group
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.02 | 2.09 | 2.79 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.79 | 1.02 | 1.97 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Ocular Therapeutix
OCUL
|
32.9 | $ 7.85 | -2.73 % | $ 1.47 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 19.59 | 0.31 % | $ 916 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Pfizer
PFE
|
2.47 | $ 27.4 | -0.63 % | $ 156 B | ||
|
Precigen
PGEN
|
100 | $ 3.83 | -1.79 % | $ 1.2 B | ||
|
Avid Bioservices
CDMO
|
3.03 | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.22 | -5.81 % | $ 311 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
PTC Therapeutics
PTCT
|
3.21 | $ 66.68 | -0.48 % | $ 5.3 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
14 | $ 0.8 | 1.48 % | $ 428 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
0.0568 | $ 13.61 | -1.16 % | $ 2.26 B | ||
|
Regeneron Pharmaceuticals
REGN
|
5.67 | $ 750.41 | -0.84 % | $ 78.5 B | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
REGENXBIO
RGNX
|
2.6 | $ 7.98 | -3.39 % | $ 412 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Rigel Pharmaceuticals
RIGL
|
2.03 | $ 26.1 | -1.02 % | $ 469 M | ||
|
Relay Therapeutics
RLAY
|
53.4 | $ 9.68 | -4.35 % | $ 1.38 B |